Dr. McIninch views psychedelic medicine work to be the singularly most rewarding aspect of her career thus far, describing it as potentially a catalyst, life-changing treatment for many people suffering from depression and anxiety.
In Jessica’s words, “I have never before seen in my 18 years as a psychologist the accelerated healing that can occur in psychedelic-assisted psychotherapy. It is such an honor to be a part of the psychedelic movement and I am delighted to bring this treatment to Hill Park’s patients.”
Jessica incorporates neuropsychological principles to amplify the effectiveness and durability of psychedelic-assisted psychotherapy and views psychedelic integration work to be equally as important as the psychedelic medicine experience itself.
Recently, Jessica was selected by MAPS (Multidisciplinary Association for Psychedelic Studies) to begin providing MDMA-assisted psychotherapy. As a Psychologist for the MAPS Expanded Access program , Jessica is providing MDMA assisted psychotherapy for individuals suffering from severe PTSD. This program, located in Washington DC, is the final phase required to achieve FDA approval of this medicine. As one of 20 clinicians in the world selected for this program, she is excited to bring this treatment to Hill Park once it becomes approved by the FDA.